3D Medicines Funding: $241M Raised, Investors & Rounds

3D Medicines funding overview

3D Medicines is based in Qingdao, Shandong, China. 3D Medicines has raised $241M in total disclosed funding. That places its disclosed total in the $100M–$250M range. The round record for 3D Medicines runs through 2020; nothing later has been disclosed. Investors on record include Efung Capital, China Capital Management, Adrian Cheng, Ruiyi Investment, Tigermed, Shanghai Ruixia and 3 others. 9 distinct backers are named across the disclosed rounds.

3D Medicines at a glance

Total raised: $241M
Latest round date: October 2020
Headquarters: Qingdao, Shandong, China
Notable investors: Efung Capital, China Capital Management, Adrian Cheng, Ruiyi Investment, Tigermed, Shanghai Ruixia, Header Capital, China Reform Holdings

Frequently asked about 3D Medicines funding

How much has 3D Medicines raised?: 3D Medicines has raised $241M in total disclosed funding across the rounds on record.
Who has invested in 3D Medicines?: Efung Capital, China Capital Management, Adrian Cheng, Ruiyi Investment, Tigermed, Shanghai Ruixia are named among the investors backing 3D Medicines.
What was the latest 3D Medicines funding round?: No round stage has been disclosed for 3D Medicines.
Where is 3D Medicines based?: 3D Medicines is based in Qingdao, Shandong, China.
When did 3D Medicines last raise?: The last disclosed 3D Medicines round closed in October 2020.

3D Medicines totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Qingdao below to benchmark round size and investor mix.

3D Medicines Funding: $241M Raised, Investors & Rounds

3D Medicines funding overview

3D Medicines at a glance

Frequently asked about 3D Medicines funding

Companies related to 3D Medicines (39)

Browse related funding lists (2)